TMO Receives FDA Approval for Oncomine Dx Target Test
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.
Cathie Wood Pounces On Peter Thiel-Backed Bullish Stock After Wild IPO Surge: Ark Buys Stock Worth $172.22 Million - ARK Fintech Innovation ETF ( BATS:ARKF ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Bullish BLSH and Shopify Inc SHOP.
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Tempus AI raises 2025 revenue outlook again after strong Q2 growth in genomics and AI-driven oncology solutions.
Cathie Wood Just Dropped $12.9 Million On This Trendy Robotaxi Stock, Ark Also Loads Up On Amazon Shares - Archer Aviation ( NYSE:ACHR ) , Amazon.com ( NASDAQ:AMZN )
On Tuesday, Cathie Wood-led Ark Invest made notable trades involving Amazon.com Inc. AMZN, Pony AI Inc. PONY, and Archer Aviation Inc. ACHR. These trades reflect Ark's strategic positioning in key sectors, including e-commerce, autonomous driving, and aviation technology.
Cathie Wood Bets $19 Million More On Jack Dorsey's Block Amid Bitcoin's All-Time High Push, Dumps Shopify Stock - ARK Fintech Innovation ETF ( BATS:ARKF )
On Monday, Cathie Wood-led Ark Invest made significant trades involving Block Inc. XYZ and Shopify Inc. SHOP.
Cathie Wood Buys the Airbnb Dip With $21.5 Million Stock Purchase, Dumps Palantir, DraftKings And Robinhood Shares - ARK Fintech Innovation ETF ( BATS:ARKF ) , Airbnb ( NASDAQ:ABNB )
On Thursday, Cathie Wood-led Ark Invest executed significant trades involving Airbnb Inc. ABNB, Robinhood Markets Inc. HOOD, Palantir Technologies Inc. PLTR, and DraftKings Inc. DKNG. These trades reflect Ark's strategic adjustments in response to recent market developments and company-specific ...
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday - AppLovin ( NASDAQ:APP ) , Advanced Micro Devices ( NASDAQ:AMD )
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Applovin Corp APP rose sharply during Thursday's session following upbeat earnings. AppLovin reported second-quarter revenue of $1.26 billion, missing analyst estimates of $1.31 billion, according ...
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Guardant Health ( NASDAQ:GH )
Guardant Health, Inc. GH reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates on Wednesday. Guardant Health raised its FY2025 sales guidance from $880.00 million-$890.00 million to $915.00 million-$925.00 million.
Guardant Health ( GH ) Q2 Revenue Up 31%
Guardant Health ( NASDAQ:GH ) , a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025. The company delivered GAAP revenue of $232.1 million, which exceeded the analyst consensus estimate of ...
Guardant Health ( GH ) Reports Q2 Loss, Beats Revenue Estimates
Guardant Health (GH) delivered earnings and revenue surprises of +15.38% and +9.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Buys The Nvidia Dip Amid Panic Over Stargate Project: Ark Swoops Up $2 Million Worth Of Hot AI Stock - ARK Space Exploration & Innovation ETF ( BATS:ARKX ) , NVIDIA ( NASDAQ:NVDA )
On Tuesday, Cathie Wood's Ark Invest made a notable move by purchasing shares of NVIDIA Corp NVDA amid concerns surrounding a significant AI project.
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs - Grayscale Ethereum Mini Trust ( ETH ) Common units of fractional undivided beneficial interest ( ARCA:ETH )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. TEM, NVIDIA Corp. NVDA, 3iQ Ether Staking ETF ( ETHQ.U ) and Coinbase Global Inc. COIN.
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz - ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests ( BATS:ARKB )
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. TSLA, Coinbase Global Inc. COIN, ARK 21Shares Bitcoin ETF ARKB and NVIDIA Corp.NVDA.
Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release
TEM's revenue and gross profit are climbing fast as new AI tools and data services boost margins ahead of Q2 earnings.
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out - Guardant Health ( NASDAQ:GH ) , Quest Diagnostics ( NYSE:DGX ) , Exact Sciences ( NASDAQ:EXAS ) , Labcorp Hldgs ( NYSE:LH )
BofA raised Tempus AI's price forecast to $70 but maintained a Neutral rating due to valuation concerns. Guardant Health, Exact Sciences, and LabCorp received Buy ratings for AI-aligned precision medicine strategies. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?
GH gains ground with stronger guidance, improving margin and Reveal's breakout as TEM scales fast but stays unprofitable.
Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?
TEM's Genomics revenues soar 89% on oncology test gains and Ambry Genetics' boost. New assays could fuel more growth.
AI Meets Oncology: Caris Life Sciences' $5.35B IPO Tests Investor Appetite for Precision Medicine - Moderna ( NASDAQ:MRNA )
Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial public offering, aiming to raise up to $423.5 million.
Aspen Ideas: Health 2025 Launches Agenda Spotlighting Bold Innovations and Urgent Challenges in Health
Aspen, CO, June 09, 2025 ( GLOBE NEWSWIRE ) -- Today, Aspen Ideas: Health, the Aspen Institute's annual premiere health gathering, launched its agenda and full speaker lineup.
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
TEM's rapid growth and cost discipline are paving the way for a positive adjusted EBITDA in 2025.
Cathie Wood Drops $373 Million On Circle's 168% Rally, Dumps Coinbase And Crypto Holdings - Is Ark Ditching Bitcoin for Stablecoins? - ARK 21Shares Bitcoin ETF Common Shares of Beneficial Interests ( BATS:ARKB )
Cathie Wood's Ark Invest made a blockbuster purchase of Circle Internet Group CRCL shares on Thursday, marking a significant move in the evolving digital assets landscape. The bold acquisition came as Ark simultaneously reshuffled its cryptocurrency stock portfolio, reducing exposure to other ...
Cathie Wood Dumps Another $5.2 Million Of Palantir Stock Amid Trump Administration-Linked Surveillance Controversy - ARK Innovation ETF ( BATS:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Wednesday, Cathie Wood's Ark Invest made a significant move by selling a substantial number of shares in Palantir Technologies Inc. PLTR. This decision comes amidst a brewing controversy surrounding the company's alleged involvement in a surveillance program.
Why Guardant Health Stock Surged Nearly 9% Higher Today
Precision oncology specialist Guardant Health ( NASDAQ: GH ) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost 9% higher today.
Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday? - Guardant Health ( NASDAQ:GH )
Shield test showed 98.6% specificity and 75% sensitivity across eight cancer types in a case-control study. NCCN now recommends the Shield blood test every three years for colorectal cancer screening. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right ...
Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday - Credo Technology Group ( NASDAQ:CRDO ) , Algonquin Power ( NYSE:AQN )
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Tuesday. Shares of Signet Jewelers Limited SIG rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and raised its FY26 guidance.
Guardant Health: A Promising Player in the Liquid Biopsy Market
Explore the exciting world of Guardant Health ( NASDAQ: GH ) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of April 9, 2025.
Is First Trust Mid Cap Growth AlphaDEX ETF ( FNY ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Guardant Health ( NASDAQ:GH ) , CNA Financial ( NYSE:CNA )
U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Monday. Shares of Netflix, Inc. ( NASDAQ: NFLX fell sharply in today's pre-market trading.
Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Robinhood Markets Inc. HOOD, Advanced Micro Devices Inc. AMD, and Palantir Technologies Inc. PLTR. The Robinhood Trade saw Ark Invest's ARK Innovation ETF ARKK fund acquire 210,714 shares of Robinhood Markets Inc.
Guardant Health ( GH ) Reports Q1 Loss, Tops Revenue Estimates
Guardant Health (GH) delivered earnings and revenue surprises of 19.67% and 6.47%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Repligen ( RGEN ) Tops Q1 Earnings and Revenue Estimates
Repligen (RGEN) delivered earnings and revenue surprises of 11.43% and 2.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Guardant Health ( NASDAQ:GH ) , Pfizer ( NYSE:PFE )
Pfizer Inc. PFE will release earnings results for the first quarter, before the opening bell on Tuesday, April 29. Analysts expect the New York-based company to report quarterly earnings at 68 cents per share, down from 82 cents per share in the year-ago period.
Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform - Guardant Health ( NASDAQ:GH ) , Pfizer ( NYSE:PFE )
Guardant and Pfizer will use liquid biopsy tests in global oncology clinical trials, including monitoring ctDNA as a therapy response marker Pfizer gains access to Guardant's testing capabilities in China through an existing partnership with Adicon Holdings. Feel unsure about the market's next ...
Amgen ( AMGN ) Earnings Expected to Grow: Should You Buy?
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Guardant Health ( GH ) Q1 Earnings Expected to Decline
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue - Guardant Health ( NASDAQ:GH )
CMS will reimburse the Shield test at $1,495 starting April 1, 2025, under ADLT status. The analyst estimates the reimbursement increase could add $10 million in revenue. The new Benzinga Rankings show you exactly how stocks stack up-scoring them across five key factors that matter most to ...
Is Guardant Health ( GH ) Outperforming Other Medical Stocks This Year?
Here is how Guardant Health (GH) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
2 Stocks Down 59% and 34% to Buy and Hold
Warren Buffett, arguably the greatest investor of all time, once said it is wise for investors to be fearful when others are greedy. One way to apply this advice from the Oracle of Omaha is to look at a soaring stock market and identify companies that aren't performing nearly as well -- or are ...
What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Guardant Health ( NASDAQ:GH )
Guardant Health Q4 adjusted EPS loss was $0.62, beating the consensus. Revenue rose 30% YoY to $201.8 million. FY25 revenue guidance is $850 million-$860 million vs. the $848.9 million consensus. Analysts raised price targets.
Guardant Health Tops Q4 Revenue Forecast
The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.
Guardant Health ( GH ) Reports Q4 Loss, Tops Revenue Estimates
Guardant Health (GH) delivered earnings and revenue surprises of -24% and 0.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Fate Therapeutics ( FATE ) Report Negative Q4 Earnings? What You Should Know
Fate Therapeutics (FATE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exploring Analyst Estimates for Guardant Health ( GH ) Q4 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Guardant Health (GH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Guardant Health ( GH ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Here's Why Guardant Health ( GH ) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Guardant Health (GH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Are Medical Stocks Lagging Guardant Health ( GH ) This Year?
Here is how Guardant Health (GH) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
